Question 1

What is the catalog number for 5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one?

Accepted Answer

The catalog number for 5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one is FP169991.

Question 2

What sizes are available for 5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one?

Accepted Answer

5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one is available in the following size(s): 5000 mg.

Question 3

Is 5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one in stock?

Accepted Answer

5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 5

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Question 6

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

5-Phenyl-3- (3H-2,3,5-triazolylamino) cyclohex-2-en-1-one

Product Specifications

CAS Number

Synonyms

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Frequently Asked Questions

Explore Other Products

CD8 (RIV11), CF647 conjugate, 0.1mg/mL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF405S conjugate, 0.1mg/mL

HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL

CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL

Human IgG Immunoglobulin (IG266), CF740 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, 0.1mg/mL